Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.452 GBX | -7.81% | -17.03% | -51.60% |
May. 08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
May. 03 | Eqtec trading in line; Surface Transforms fundraise | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Renewable Energy Equipment & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-51.60% | 3.57M | - | ||
+19.26% | 21.23B | B | ||
-26.60% | 6.28B | B | ||
-18.50% | 3.06B | C+ | ||
-26.08% | 2.31B | B | ||
-25.54% | 1.9B | D+ | ||
-20.88% | 1.21B | - | ||
+4.71% | 1.11B | - | - | |
-10.01% | 909M | - | ||
+86.66% | 915M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- REAC Stock
- Ratings EQTEC plc